Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Silodosin for Prevention of Postoperative Urinary Retention
TCTR20191226003Phase 4Active, not recruiting
- Sponsor
- Ramathibodhi Hospital
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of silodosin in postoperative urinary retention (POUR), sponsored by Ramathibodhi Hospital. Started Aug 2019; status: active, not recruiting.
02
Drugs
silodosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on TCTR20191226003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191226003.